Immunotherapy: Introduction and overview

Immunology and Allergy Clinics of North America

Volumn 20, Issue 3, 2000, Pages 469-478

  Reisman, Robert E ^b   Tronolone, Michael J ^b  

^a Buffalo Medical Group   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN;

ALLERGIC DISEASE; ALLERGIC RHINITIS; ASTHMA; HYPERSENSITIVITY REACTION; IMMUNE RESPONSE; IMMUNOTHERAPY; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; REVIEW; SENSITIZATION;

EID: 0033811428     PISSN: 08898561     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8561(05)70161-2     Document Type: Article

References (33)

1. A controlled trial of immunotherapy for asthma in allergic children
2. Immunologic studies of ragweed-sensitive patients. III. Clinical aspects: The relationship of reagin and hemagglutinating antibody titers to results of hyposensitization therapy
3. Local nasal immunotherapy
4. Allergen immunotherapy: Therapeutic vaccines for allergic disease
5. The treatment of ragweed pollinosis with a single annual emulsified extract injection II
6. Hay fever and asthma: The uses and limitations of desensitization
7. Immunotherapy in adult asthma
8. Long-term clinical efficacy of grass pollen immunotherapy
9. Further observations on the treatment of hay fever by hypodermic inoculations of pollen vaccine
10. Vaccination against hay fever: Report of results during the last 3 years
11. Sublingual immunotherapy
12. The clinical evaluation and the preparation and standardization of suspensions of a new water insoluble who ragweed pollen complex
13. Modified forms of allergen immunotherapy
14. Persistence of efficacy after a brief course of polymerized ragweed allergens: A controlled Study
15. Immunotherapy as preventive allergy treatment (PAT)
16. The value of hyposensitization therapy for bronchial asthma in children: A 14-year study
17. Double-blind, placebo-controlled evaluation of sublingual swallow immunotherapy with standardized Parietaria judaica extract in children with allergic rhinoconjunctivitis
18. Antibody response following immunotherapy in ragweed hay fever: Allpyral versus whole ragweed extract
19. Studies of the mechanism of hypersensitivity phenomena. IX: Histamine release from human leukocytes by ragweed pollen antigen
20. 2 of bee venom
21. Fatalities from immunotherapy and skin testing
22. Immunological studies of pollinosis. I: The presence of two antibodies related to the same pollen-antigen in the serum of treated hay fever patients
23. Immunological studies of pollinosis. IV: The relationship between thermostable antibody in the circulation and clinical immunity
24. Studies on 'allergoids' prepared from naturally occurring allergens. I: Assay of allergenicity and antigenicity of formalinized rye group I component
25. Local intranasal immunotherapy for ragweed allergic rhinitis. I: Clinical response
26. Local intranasal immunotherapy for ragweed allergic rhinitis. II: Immunologic response
27. Prophylactic inoculation against hay fever
28. Controlled evaluations of respiratory therapy in ragweed hay fever
29. Studies on supersensitivity
30. Venom hypersensitivity
31. Clinical studies of two new ragweed preparations: 'Purified' delta and Allpyral
32. Immunotherapy with antigen E
33. The effect of hyposensitization on the in vitro histamine release by specific antigen